Severe Obesity Linked to Lower Rates of Cancer Screening, Study Finds

A recent large-scale study in the United States reveals that adults with severe obesity are significantly less likely to receive recommended cancer screenings, raising concerns over disparities in cancer prevention and early detection. Published in JAMA Network Open and involving more than two million participants, the research highlights an urgent need for equity-focused public health strategies to improve cancer screening access among individuals with severe obesity. This finding is especially important given obesity’s established role as a risk factor for multiple cancers.

Key Findings and Study Details

The study analyzed data from 2,057,525 U.S. adults aged around 55 years on average, collected over multiple years (2012-2020) through the Behavioral Risk Factor Surveillance System. Participants were categorized by body mass index (BMI) into five groups: normal/overweight (18.5-29.9), three classes of obesity (30.0-34.9; 35.0-39.9; 40.0-49.9), and severe obesity (BMI ≥ 50.0).

The researchers found that adults with severe obesity (BMI ≥ 50.0) were less likely to undergo colonoscopy or sigmoidoscopy, with an 8% reduction in screening compared to those with BMI 18.5-29.9. Similarly, prostate-specific antigen (PSA) testing rates were lower in this group. Mammography rates also declined with increasing BMI, although this decline was not statistically significant after adjustments. Conversely, fecal occult blood testing rates increased with higher BMI. Pap smear testing was marginally lower in severely obese adults.

According to the lead author, Dr. Florina Corpodean from the Metamor Institute, these results underscore the critical need for targeted interventions to improve screening uptake among severely obese adults, who face elevated cancer risk yet are under-screened.

Context: Obesity and Cancer Screening

Obesity is a well-known risk factor for at least 13 cancers, including colon, breast, endometrial, and kidney cancers. Despite this elevated risk, multiple barriers limit cancer screening in people with obesity. These barriers include physical difficulties with screening procedures, stigma or discrimination during healthcare visits, and possible provider biases or inadequate equipment to accommodate larger body sizes.

Dr. Faizan Ahmed, an oncologist not involved in the study, remarks, “The paradox of higher cancer risk yet lower screening rates in obesity reflects systemic issues in healthcare access and delivery. Addressing these gaps is key to reducing cancer disparities”.

Public Health Implications and Recommendations

The study’s findings have direct implications for public health policy and clinical practice. Increasing cancer screening rates among severely obese adults could be lifesaving by enabling earlier cancer diagnosis and treatment. Experts advocate for:

• Enhanced provider training to reduce stigma and improve communication with patients with obesity

• Availability of appropriately sized medical equipment for screening procedures

• Tailored patient education and outreach programs emphasizing the importance of screening regardless of body size

• Structural changes to reduce healthcare access disparities related to socioeconomic factors often accompanying obesity

Limitations and Considerations

The study’s reliance on self-reported data introduces potential bias, and the cross-sectional design limits causality conclusions. Some differences in screening rates, while statistically significant, were small and may not reflect clinically meaningful gaps. The research did not explore the specific reasons behind lower screening uptake, which can include personal, cultural, or systemic factors.

Balanced Reporting

While this study highlights lower screening rates for certain procedures among severely obese adults, it also observed increased fecal occult blood testing in this group, indicating some adaptation in screening practice. Additionally, the results do not imply that all individuals with obesity face screening barriers, underscoring the need for personalized approaches.

Practical Takeaway for Readers

For health-conscious individuals, especially those with obesity, this research emphasizes the importance of staying proactive about cancer screenings. Patients should openly discuss screening options with healthcare providers, addressing any concerns or barriers related to body size. Providers should work to create welcoming and accommodating environments to ensure equitable preventive care.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References